Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Cancer. 2016 Nov 8;123(6):1035–1043. doi: 10.1002/cncr.30446

Table 4. Pre-diagnostic wine consumption and disease-specific survival after colorectal cancer diagnosis by patient and tumor attributes.

No wine
(<1 serving/week)
≤1 serving/day of wine
(≥1 serving/week)
>1 servings/day of wine

N (deaths) HR (95% CI)* N (deaths) HR (95% CI)* P N (deaths) HR (95% CI)* P
Sex
 Male 1622 (423) 1.0 (ref) 527 (121) 0.85 (0.66-1.10) 0.22 131 (24) 0.57 (0.34-0.97) 0.04
 Female 1552 (349) 1.0 (ref) 468 (101) 1.10 (0.83-1.46) 0.50 88 (18) 0.92 (0.56-1.52) 0.76
Age at diagnosis
 ≤50 1499 (363) 1.0 (ref) 485 (109) 1.01 (0.78-1.30) 0.94 82 (13) 0.63 (0.34-1.18) 0.15
 >50 1675 (409) 1.0 (ref) 510 (113) 0.93 (0.71-1.22) 0.59 137 (29) 0.74 (0.46-1.18) 0.20
Smoking history
 Never smoker 1408 (302) 1.0 (ref) 432 (92) 1.01 (0.76-1.34) 0.88 64 (9) 0.82 (0.39-1.73) 0.59
 Former smoker 1159 (300) 1.0 (ref) 441 (86) 0.70 (0.51-0.96) 0.01 108 (21) 0.59 (0.36-0.98) 0.04
 Current smoker 607 (170) 1.0 (ref) 122 (44) 1.80 (1.21-2.67) 0.004 47 (12) 0.82 (0.40-1.68) 0.64
Tumor site
 Right-sided 1100 (260) 1.0 (ref) 330 (86) 1.31 (0.98-1.76) 0.07 63 (14) 0.92 (0.48-1.75) 0.79
 Left-sided 943 (201) 1.0 (ref) 256 (42) 0.76 (0.49-1.20) 0.24 62 (9) 0.44 (0.20-0.96) 0.04
 Rectal 1103 (302) 1.0 (ref) 397 (91) 0.89 (0.66-1.20) 0.45 94(19) 0.72 (0.42-1.22) 0.22
MMR status
 Proficient 2154 (558) 1.0 (ref) 740 (172) 0.91 (0.73-1.13) 0.39 164 (35) 0.76 (0.51-1.15) 0.19
 Deficient 374 (44) 1.0 (ref) 96 (7) 0.56 (0.24-1.33) 0.19 21 (2) --
BRAF-mutation status
 Wildtype 1816 (435) 1.0 (ref) 666 (138) 0.90 (0.71-1.14) 0.39 156 (35) 0.80 (0.53-1.23) 0.32
 Mutated 243 (44) 1.0 (ref) 72 (20) 1.76 (0.93-3.33) 0.08 19 (3) --
CIMP status 1.0 (ref) 464 (106) 0.82 (0.62-1.09) 0.18 115 (25) 0.71 (0.44-1.16) 0.18
 Non-CIMP 1346 (356)
 CIMP-high 242 (51) 1.0 (ref) 54 (13) 0.96 (0.46-1.99) 0.91 11 (3) --

Unadjusted 5-year survival %: <1 serving/week (80.2%), ≤1 serving/day (≥1 serving/week) (81.4%), >1 serving/day (84.7%)

*

Adjusted for age at diagnosis, year of diagnosis, sex, smoking history, body mass index, education, study site

-- Result based on <5 deaths in one comparison group